MedPath

To compare two adjuvent magnesium sulphate and dexmeditomidine with bupivacaine in spinal anasthesia

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2019/02/017796
Lead Sponsor
Department of anaesthesiology Jln Medical College ajmer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age group between 18 and 65 years.

2.Body weight 30 to 80 kg.

3.Patients belonging ASA class-I & II.

4.Patients undergoing infraumbilical surgeries of duration 1-4 hours.

Exclusion Criteria

1.Patients refusal.

2.Uncooperative patients.

3.Any known hypersensitivity or contraindication to Bupivacaine, Dexmedetomidine and Magnesium sulfate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of effective analgesia by visual analog scale (VAS).Timepoint: Duration of study around 1year
Secondary Outcome Measures
NameTimeMethod
Duration of sensory block. <br/ ><br>Duration of motor block <br/ ><br>Peri-operative sedation Score. <br/ ><br>Hemodynamic changes if any <br/ ><br>Adverse effects if anyTimepoint: Duration of study is around one year
© Copyright 2025. All Rights Reserved by MedPath